It is a complex of sulfates of heparin, dermatan and chondroitin. It acts through antithrombin III. It is anti-factor Xa and to a lesser extent it is also inhibitor of thrombin.
It is obtained from porcine mucosa.
Administration and elimination:
It is administered subcutaneously and is eliminated through kidneys.
Prophylactically, it is used in deep vein thrombosis in hip replacement surgery.
It is effective in Type-II, heparin induced thrombocytopenia.
Allergic reactions such as anaphylaxis or asthma may develop. Hemorrhage may occur.
Excess danaparoid can be displaced by plasmapheresis.